Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,079 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple neural mechanisms for coloring words in synesthesia.
Yokoyama T, Noguchi Y, Koga H, Tachibana R, Saiki J, Kakigi R, Kita S. Yokoyama T, et al. Among authors: koga h. Neuroimage. 2014 Jul 1;94:360-371. doi: 10.1016/j.neuroimage.2014.01.039. Epub 2014 Jan 29. Neuroimage. 2014. PMID: 24486829 Clinical Trial.
C-type natriuretic peptide suppresses VEGFa gene expression by attenuating IL6-STAT3 signal pathway in primary synovial fibroblasts from rat knee.
Yamashita R, Nozawa I, Hasegawa S, Nakagawa Y, Miyatake K, Katagiri H, Nakamura T, Koga H, Sekiya I, Yoshii T, Tsuji K. Yamashita R, et al. Among authors: koga h. Biochem Biophys Res Commun. 2025 Jan 20;749:151290. doi: 10.1016/j.bbrc.2025.151290. Online ahead of print. Biochem Biophys Res Commun. 2025. PMID: 39855042
The BRAAFF-Annotated Acral Lesions Dataset (BALD): A curated set of dermatoscopic images of acral melanoma and nevi from various sources.
Müller C, Tschandl P, Rinner C, Kyrgidis A, Koga H, Moscarella E, Apalla Z, Di Stefani A, Kobayashi K, Lazaridou E, Longo C, Phan A, Saida T, Sotiriou E, Tanaka M, Thomas L, Zalaudek I, Argenziano G, Lallas A, Kittler H. Müller C, et al. Among authors: koga h. J Invest Dermatol. 2025 Jan 17:S0022-202X(25)00021-1. doi: 10.1016/j.jid.2024.12.021. Online ahead of print. J Invest Dermatol. 2025. PMID: 39827926 Free article. No abstract available.
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.
Sangro B, Kudo M, Erinjeri JP, Qin S, Ren Z, Chan SL, Arai Y, Heo J, Mai A, Escobar J, Lopez Chuken YA, Yoon JH, Tak WY, Breder VV, Suttichaimongkol T, Bouattour M, Lin SM, Peron JM, Nguyen QT, Yan L, Chiu CF, Santos FA, Veluvolu A, Thungappa SC, Matos M, Żotkiewicz M, Udoye SI, Kurland JF, Cohen GJ, Lencioni R; EMERALD-1 Investigators. Sangro B, et al. Lancet. 2025 Jan 18;405(10474):216-232. doi: 10.1016/S0140-6736(24)02551-0. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798579 Clinical Trial.
2,079 results